Tracked changes to cannabis law across every jurisdiction we cover.
Summaries of changes, not legal advice. Check the official source.
After years of delays, prescriptions for medical cannabis became available through Greek pharmacies in 2024, building on the 2017 medical decision and the 2018 production law.
Since 17 June 2026 unlicensed export of cannabis is charged under the Customs Act, with up to 10 years in prison and heavy fines.
On 20 July 2026 the Department of Thai Traditional and Alternative Medicine sent the completed draft, renamed the Cannabis Control Act, to the Public Health Minister. Cabinet approval comes next, and parliament is not expected to consider it before 2027.
The 0.4 mg per container limit on total THC in hemp products, due on 12 November 2026, was moved to 11 December 2026 by the stopgap funding law signed on 2 September 2026. Synthetic cannabinoids are still banned from 12 November.
On 23 April 2026 the Justice Department moved marijuana in FDA approved medicines and marijuana under a state medical marijuana licence to Schedule III. All other marijuana, including adult use, stays in Schedule I.
Federal amendments in force since 12 March 2025 allow see through packaging for dried cannabis, QR codes and inserts, pre rolls over 1 g, and remove the 10 mg cap on an outer box of edibles (each package inside still holds at most 10 mg of THC).
On 1 July 2025 the Food Standards Agency asked CBD food businesses to reformulate products to its safety limits: no more than 10 mg of CBD and 0.07 mg of THC a day for a healthy adult, with the daily limit shown on the label.
The Advisory Council on the Misuse of Drugs is reviewing whether the 2018 change that allowed cannabis prescriptions worked as intended. Its call for evidence ran from 17 September to 17 October 2025, and the findings on prescribing, private clinics and NHS access are expected by the end of 2026.
From 1 January 2025, licensed retailers with on site consumption permits may serve non infused food and drinks and host live entertainment, where the city or county allows it. Alcohol remains banned.
The state cannabis excise tax rose from 15% to 19% on 1 July 2025. AB 564, signed on 22 September 2025, brought it back to 15% and froze it there through June 2028.
The Cannabis Control Board adopted updated medical rules in July 2026: patient certifications can last up to two years, patients may hold up to a 60 day supply or 3 ounces and 24 g of concentrate, whichever is greater, and qualifying out of state patients will be able to buy medical products in New York.
A 2025 legislative push to raise the retail purchase limit from 1 to 2 ounces did not pass, so stores still sell up to 1 ounce per transaction while adults may possess up to 2 ounces.
IRCCA data show pharmacies sold about 4,290 kg of cannabis in 2025, up from 3,207 kg in 2024, with the strongest variety (Epsilon, up to 20% THC) the most requested. 83,567 people were registered to buy in pharmacies at the end of 2025.
Parliament unanimously approved amendments on 12 May 2025: a clearer legal definition of cannabis (non psychoactive products under 0.2% THC excluded), a 250 m minimum distance from schools, sports facilities and youth centres, and fines of up to 10,000 euros for associations that admit minors. ARUC also allowed associations to supply solventless resin.
Law 55/2023, published and in force on 8 September 2023, changed the drug law so that holding more than a ten day supply is not automatically treated as a crime when it is for personal use; the burden is on the police to show trafficking. It also brought synthetic drugs under the decriminalisation framework.
Spain approved its first rules for medical cannabis on 7 October 2025: standardised preparations registered with the AEMPS, prescribed by hospital specialists and prepared and dispensed by hospital pharmacies. The decree entered into force on 10 October 2025.
The National Council's health committee adopted a draft law in February 2025 that would allow adults to buy cannabis from licensed, non profit outlets and grow three plants at home. After the consultation (August to December 2025), in which a majority of cantons were critical, the committee decided in May 2026 to continue the work but sent the text back to a subcommittee to revise youth protection, cantonal enforcement and online sales. No plenary debate is scheduled yet.
The second interim report of the official evaluation (1 April 2026) found no significant rise in consumption in wastewater data, more people growing at home and no major increase in cannabis related hospital cases. The full evaluation runs until 2028.
The government bill to amend the Medical Cannabis Act (Bundestag printed paper 21/3061, December 2025) would require an in person consultation before the first flower prescription and at least once a year after that, and would end postal delivery of flower. It had not passed the Bundestag by September 2026.
The GKV contribution rate stabilisation act removed cannabis flower from the special entitlement in section 31(6) of the Social Code Book V from 30 July 2026. Extracts, dronabinol and nabilone remain reimbursable; flower stays available on private prescription.
California's Department of Cannabis Control continues to update advertising, testing and delivery rules, check the DCC rulemaking page before campaign launches.
The FOPH approved the CanLeg trial in St. Gallen in June 2026, the eighth adult use pilot and the first to test delivery to participants' homes. Zurich extended its Züri Can trial to October 2028, and interim results from the SCRIPT trial in Bern, Biel and Lucerne (September 2026) showed no rise in consumption.
The second pillar of the reform, regional pilot projects with licensed commercial sales, has not started. The coalition agreed to wait for the full evaluation of the Cannabis Act, due in 2028, before changing the law.
A DEA hearing on moving all marijuana to Schedule III ran from 29 June to 15 July 2026. On 29 September 2026 the judge paused the proceeding to decide whether to add a new GAO report to the record; responses are due on 13 October and there is no set date for a decision.
From 7 April 2025 coffeeshops in the ten participating municipalities may sell only cannabis from designated growers. The start had been planned for September 2024 and was postponed. Enforcement of the hashish part followed on 1 September 2025.